SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-037289
Filing Date
2024-04-29
Accepted
2024-04-29 17:20:44
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0204715-10ka1_nkgen.htm   iXBRL 10-K/A 591454
2 CERTIFICATION ea020471501ex31-1_nkgen.htm EX-31.1 8458
3 CERTIFICATION ea020471501ex31-2_nkgen.htm EX-31.2 8469
4 CERTIFICATION ea020471501ex32-1_nkgen.htm EX-32.1 3756
5 CLAWBACK POLICY ea020471501ex97-1_nkgen.htm EX-97.1 38454
  Complete submission text file 0001213900-24-037289.txt   980411

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nkgn-20231231.xsd EX-101.SCH 3812
7 XBRL DEFINITION FILE nkgn-20231231_def.xml EX-101.DEF 19079
8 XBRL LABEL FILE nkgn-20231231_lab.xml EX-101.LAB 38587
9 XBRL PRESENTATION FILE nkgn-20231231_pre.xml EX-101.PRE 19838
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0204715-10ka1_nkgen_htm.xml XML 8787
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40427 | Film No.: 24892856
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)